CAS # 123948-87-8
Pharma / Injectable Grade (MW 421.4 g/mol)
Topotecan / Topotecan HCl Topoisomerase I Inhibitor
Topotecan is a semi-synthetic camptothecin derivative Topoisomerase I inhibitor used in metastatic ovarian cancer, Small Cell Lung Cancer (SCLC), and advanced cervical cancer.
Assay / Purity
≥ 98.0% (C23H23N3O5)
Physical Appearance
Light Yellow to Greenish Powder
Documentation
CoA / DMF / GMP
Direct Procurement Quote
Fill details to receive commercial terms and Certificate of Analysis (CoA).
Technical Specifications Summary
Chemical / Product Name
Topotecan / Topotecan HCl Topoisomerase I Inhibitor
CAS Registry Number
123948-87-8
Standard Grade
Pharma / Injectable Grade (MW 421.4 g/mol)
Assay / Purity
≥ 98.0% (C23H23N3O5)
Appearance
Light Yellow to Greenish Powder
Formulation & Industry Applications
Injectable Formulations
Topotecan Hydrochloride Vials
Related Ingredients
Explore complementary ingredients in Oncology APIs Portfolio: